These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18307035)
1. Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90. Suuronen T; Ojala J; Hyttinen JM; Kaarniranta K; Thornell A; Kyrylenko S; Salminen A Neurochem Res; 2008 Sep; 33(9):1768-75. PubMed ID: 18307035 [TBL] [Abstract][Full Text] [Related]
2. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90. Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868 [TBL] [Abstract][Full Text] [Related]
3. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status. Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells. Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952 [TBL] [Abstract][Full Text] [Related]
5. Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Yang Y; Rao R; Shen J; Tang Y; Fiskus W; Nechtman J; Atadja P; Bhalla K Cancer Res; 2008 Jun; 68(12):4833-42. PubMed ID: 18559531 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells. Vanneste M; Hanoux V; Bouakka M; Bonnamy PJ Mol Cell Endocrinol; 2017 Mar; 444():48-58. PubMed ID: 28137613 [TBL] [Abstract][Full Text] [Related]
7. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Sharma D; Saxena NK; Davidson NE; Vertino PM Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215 [TBL] [Abstract][Full Text] [Related]
8. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Kumar A; Klinge CM; Goldstein RE Int J Oncol; 2010 May; 36(5):1067-80. PubMed ID: 20372779 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells. Patki M; Salazar Md; Trumbly R; Ratnam M Biochem Biophys Res Commun; 2015 Feb; 457(3):404-11. PubMed ID: 25582774 [TBL] [Abstract][Full Text] [Related]
11. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142 [TBL] [Abstract][Full Text] [Related]
13. Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90. Meng Q; Chen X; Sun L; Zhao C; Sui G; Cai L Mol Cell Biochem; 2011 Feb; 348(1-2):165-71. PubMed ID: 21082217 [TBL] [Abstract][Full Text] [Related]
14. Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha. Shi YE; Chen Y; Dackour R; Potters L; Wang S; Ding Q; Wang Z; Liu YE Am J Pathol; 2010 Aug; 177(2):964-73. PubMed ID: 20595634 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells. Hodges-Gallagher L; Valentine CD; Bader SE; Kushner PJ Breast Cancer Res Treat; 2007 Nov; 105(3):297-309. PubMed ID: 17186358 [TBL] [Abstract][Full Text] [Related]
16. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of potential implication of membrane estrogen binding sites on ERE-dependent transcriptional activity and intracellular estrogen receptor-alpha regulation in MCF-7 breast cancer cells. Seo HS; Leclercq G J Steroid Biochem Mol Biol; 2002 Jan; 80(1):109-23. PubMed ID: 11867270 [TBL] [Abstract][Full Text] [Related]
18. Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle. Han G; Ma H; Chintala R; Fulton DJ; Barman SA; White RE J Pharmacol Exp Ther; 2009 Jun; 329(3):850-5. PubMed ID: 19293389 [TBL] [Abstract][Full Text] [Related]
19. Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells. Chen X; Danes C; Lowe M; Herliczek TW; Keyomarsi K J Natl Cancer Inst; 2000 Sep; 92(17):1403-13. PubMed ID: 10974076 [TBL] [Abstract][Full Text] [Related]
20. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. Lee AV; Weng CN; Jackson JG; Yee D J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]